Locate providers:   

Osyris Medical U.S.A. Names Ron Borsheim as Director of Business Development and Special Projects

 

Ron Borsheim brings fourteen years of experience to the next generation of Laser Lipolysis.

osyris medical logoDallas, TX (PRWEB) June 26, 2009 -- Ron Borsheim joins Osyris Medical U.S.A. one year after the U.S. arm of the international leading laser company, Osyris Medical, made a strong debut in the American {!laser-assisted lipolysis | laser lipolysis} market by offering the new generation of lasers. Osyris Medical U.S.A. is a new company that is a well-established and highly-regarded developer and manufacturer of leading laser-assisted lipolysis devices and products.

Osyris Medical U.S.A. hired Mr. Borsheim as the Director of Business Development and Special Projects to address the company's next generation of laser lipolysis, which is includes the diode laser {!Lipotherme? | Lipotherme} as well as LipoControl? (currently pending FDA clearance.) LipoControl will be the first and only laser lipolysis device with total treatment control. Lipotherme, which made a strong debut in the U.S. one year earlier, is a 980 nm continuous wave diode laser that can be adjusted from 1 watt to 25 watts of power. LipoControl includes an on-screen video mapping technology that shows treatment and energy delivery in real-time.

"After spending over a decade working for leading technology companies, I saw first hand the issues in the medical aesthetics industry, and the technological advances that Osyris Medical U.S.A. is using to address these concerns. I am very excited to be part of a company that specifically has their finger on the future pulse of the medical aesthetics industry," says Mr. Borsheim. "I am also honored to have the opportunity to work with the dream team that they have put together. Osyris Medical U.S.A. has created a leading management team compromised of the stars in the market place and I am proud to be a part of this organization."

"I believe that Ron's many years of laser experience will be in invaluable in continuing to grow the Osyris Medical brand not only in the United States, but around the world," said John Eubank, Vice President of Sales for Osyris Medical U.S.A.

Prior to joining Osyris Medical U.S.A., Mr. Borsheim worked for Cynosure where he played a key role in launching the SmartLipo system. In addition, he was the Director of International Sales Development and was a key contributor in growing Cynosure's global market to $43 million in revenue for 2008. Readers interested in learning more about Osyris Medical U.S.A. at www.osyrismedicalusa.com or call 972-720-0425.

Osyris Medical U.S.A. is the American extension of the international leading medical laser company, Osyris Medical. Based in Dallas, TX, Osyris Medical U.S.A. provides the world's leading medical aesthetic devices focused on current and emerging technologies in skin tightening, skin rejuvenation, body contouring that are scientifically proven, clinically validated and have the highest consumer demand.